Chao, C C, Janoff, E N, Hu, S X et al. · Cytokine · 1991 · DOI
This study found that immune cells from people with ME/CFS respond differently to stimulation than cells from healthy people. Specifically, when researchers activated these immune cells in the lab, they released higher levels of inflammatory molecules (IL-1 beta, IL-6, and TNF-alpha), suggesting that ME/CFS patients' immune cells may be in a heightened state of readiness. The study also found unusual patterns in a molecule called TGF-beta, which normally helps regulate immune responses.
This study provides early mechanistic evidence that ME/CFS involves measurable immune dysregulation—specifically a primed innate immune response—rather than purely psychological causes. Understanding how immune cells behave abnormally in ME/CFS may eventually lead to biomarkers for diagnosis and targeted therapeutic interventions.
This study does not prove that immune cell dysregulation causes ME/CFS symptoms or that correcting these cytokine abnormalities will improve patient outcomes. The in vitro findings may not fully reflect what occurs in the body, and the cross-sectional design cannot establish temporal relationships or whether these immune changes persist over time.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →